The associated article is a meta-analysis reviewing published studies for SBRT for HCC with 5+ years of outcome data. 19 studies were identified that met the criteria. The article reviews those 19 studies and makes recommendations for appropriate SBRT for HCC.

Recent publications have established SBRT as the standard of care in painful spine metastases. As a result, spine SBRT is being increasingly utilized in both academic and community practices, rendering this educational activity timely.

This activity reviews the various oligometastatic states, existing and upcoming data supporting radiation in appropriately selected patients, intersection of radiation with systemic therapy, and practical applications of radiation treatment delivery with a focus on stereotactic ablative radiation

This activity provides an opportunity to understand the key steps in the process of care for SBRT treatment of liver (primary and metastases), focusing on patient selection, imaging, simulation, treatment planning and image guidance, and discuss challenges in motion management and delivery.

This activity focuses on difficult cases in the use of lung SBRT. It includes a set of challenging cases followed by a short didactic session on each challenging topic. The cases/topics include: 1) SBRT for a large (>5 cm) primary, node negative tumor.

This session reviews the recent data for the sequence and timing of targeted therapies and immune checkpoint inhibitors and radiation therapy for patients with brain metastases.

The purpose of this educational lecture will be to review recent data on treatment of oligometastases, and to discuss practical approaches to treatment at different locations.

The purpose of this educational lecture will be to review recent data on treatment of oligometastases, and to discuss practical approaches to treatment at different locations.

The field of cancer is a rapidly evolving field with new treatment approaches moving to clinic on a daily basis. Radiation Oncology is no different. It is extremely difficult for a practicing clinician to stay abreast of new developments in cancer care.